195
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effects of amniotic and maternal CD-146, TGF-β1, IL-12, IL-18 and Inf-γ, on adverse pregnancy outcome

, , &
Pages 21-25 | Received 13 Jan 2012, Accepted 07 Aug 2012, Published online: 11 Sep 2012

References

  • Squire JA, Nauth L, Ridler MA, Sutton S, Timberlake C. Prenatal diagnosis and outcome of pregnancy in 2036 women investigated by amniocentesis. Hum Genet 1982;61:215–222.
  • Sangalli M, Langdana F, Thurlow C. Pregnancy loss rate following routine genetic amniocentesis at Wellington Hospital. N Z Med J 2004;117:1–5.
  • Wilson R, Moor J, Jenkins C, Miller H, Walker JJ, McLean MA, Norman J, McInnes IB. Abnormal first trimester serum interleukin 18 levels are associated with a poor outcome in women with a history of recurrent miscarriage. Am J Reprod Immunol 2004;51:156–159.
  • Paradisi R, Porcu E, Venturoli S, Maldini-Casadei M, Boni P. Maternal serum levels of pro-inflammatory cytokines in missed and threatened abortion. Am J Reprod Immunol 2003;50:302–308.
  • Pasquier E, Bardin N, De Saint Martin L, Le Martelot MT, Bohec C, Roche S, Mottier D, Dignat-George F. The first assessment of soluble CD146 in women with unexplained pregnancy loss. A new insight? Thromb Haemost 2005;94:1280–1284.
  • Wilson R, McInnes I, Leung B, McKillop JH, Walker JJ. Altered interleukin 12 and nitric oxide levels in recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 1997;75:211–214.
  • Reina M, Broccia ML, Menegola E, Di Blasio AM, Vigano P, Giavini E. Effects of interleukin-12 administration during the pre- and periimplantationn period on mouse embryofetal development. AJRI 2004;51:345–351.
  • Puchner K, Iavazzo C, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Kouskouni E, et al. Mid-trimester amniotic fluid interleukins (IL-1β, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo 2011;25:141–148.
  • Daskalakis G, Thomakos N, Papapanagiotou A, Papantoniou N, Mesogitis S, Antsaklis A. Amniotic fluid interleukin-18 at mid-trimester genetic amniocentesis: relationship to intraamniotic microbial invasion and preterm delivery. BJOG 2009;116:1743–1748.
  • Mansouri R, Akbari F, Vodjgani M, Mahboudi F, Kalantar F, Mirahmadian M. Serum cytokines profiles in Iranian patients with preeclampsia. Iran J Immunol 2007;4:179–185.
  • Ekelund CK, Vogel I, Skogstrand K, Thorsen P, Hougaard DM, Langhoff-Roos J, Jacobsson B. Interleukin-18 and interleukin-12 in maternal serum and spontaneous preterm delivery. J Reprod Immunol 2008;77:179–185.
  • Ostojic S, Volk M, Medica I, Kapovic M, Meden-Vrtovec H, Peterlin B. Polymorphisms in the interleukin-12/18 genes and recurrent spontaneous abortion. Am J Reprod Immunol 2007;58:403–408.
  • Lédée-Bataille N, Dubanchet S, Coulomb-L’hermine A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004;81:59–65.
  • Liu Q, Yan X, Li Y, Zhang Y, Zhao X, Shen Y. Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblast. Lab Invest 2004;84:221–228.
  • Liu Q, Zhang B, Zhao X, Zhang Y, Liu Y, Yan X. Blockade of adhesion molecule CD146 causes pregnancy failure in mice. J Cell Physiol 2008;215:621–626.
  • Shynlova O, Tsui P, Dorogin A, Langille BL, Lye SJ. The expression of transforming growth factor b in pregnant rat myometrium is hormone and stretch dependent. Reproduction 2007;134:503–511.
  • Amani D, Dehaghani AS, Zolghadri J, Ravangard F, Niikawa N, Yoshiura KI, Ghaderi A. Lack of association between the TGF-_1 gene polymorphisms and recurrent spontaneous abortion. J Reprod Immunol 2005;68:91–103.
  • Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol 2004;52:36–41.
  • Daher S, de Arruda Geraldes Denardi K, Blotta MH, Mamoni RL, Reck AP, Camano L, Mattar R. Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004;62:151–157.
  • Neta GI, von Ehrenstein OS, Goldman LR, Lum K, Sundaram R, Andrews W, Zhang J. Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth. Am J Epidemiol 2010;171:859–867.
  • Holst RM, Hagberg H, Wennerholm UB, Skogstrand K, Thorsen P, Jacobsson B. Prediction of spontaneous preterm delivery in women with preterm labor: analysis of multiple proteins in amniotic and cervical fluids. Obstet Gynecol 2009;114:268–277.
  • Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J, Croy BA. Interferon gamma in successful pregnancies. Biol Reprod 2009;80:848–859.
  • Heyborne KD, Witkin SS, McGregor JA. Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol 1992;167:920–925.
  • Heyborne KD, McGregor JA, Henry G, Witkin SS, Abrams JS. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994;171:55–59.
  • Ghidini A, Jenkins CB, Spong CY, Pezzullo JC, Salafia CM, Eglinton GS. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol 1997;37:227–231.
  • Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998;178:546–550.
  • Murakawa H, Mori S, Iida S, Atsumi Y, Suzuki M. The relationship between amniotic fluid macrophage colony-stimulating factor and fetal growth. J Reprod Immunol 1998;37:163–170.
  • Hayashi M, Zhu K, Sagesaka T, Fukasawa I, Inaba N. Elevation of amniotic fluid macrophage colony-stimulating factor in normotensive pregnancies that delivered small-for-gestational-age infants. Am J Reprod Immunol 2007;57:488–494.
  • Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS, Jun JK. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001;185:1162–1167.
  • Apuzzio J, Chan Y, Al-Khan A, Illsley N, Kim PL, Vonhaggen S. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery. J Matern Fetal Neonatal Med 2004;15:313–317.
  • Thomakos N, Daskalakis G, Papapanagiotou A, Papantoniou N, Mesogitis S, Antsaklis A. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur J Obstet Gynecol Reprod Biol 2010;148:147–151.
  • Pressman EK, Thornburg LL, Glantz JC, Earhart A, Wall PD, Ashraf M, Pryhuber GS, Woods JR Jr. Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome. Am J Obstet Gynecol 2011;204:155.e1–155.e7.
  • Bamberg C, Fotopoulou C, Thiem D, Roehr CC, Dudenhausen JW, Kalache KD. Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia. J Matern Fetal Neonatal Med 2012;25:812–817.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.